ArticleEuropean journal of nuclear medicine and molecular imaging2010

In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin.

Thorsten Petrich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.